|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Liver Disease
|
NCI
|
4R37CA053394-17
|
|
Mechanism of action of the v-erb A oncogene of AEV.
|
PRIVALSKY, MARTIN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$300,645
|
|
Liver Disease
|
NCI
|
5R01CA082723-09
|
|
K Vitamins- A New Class of Liver Cell Growth Inhibitors
|
CARR, BRIAN
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$263,832
|
|
Liver Disease
|
NIDA
|
1K23DA020383-01A1
|
|
Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users
|
TAYLOR, LYNN
|
MIRIAM HOSPITAL
|
RI
|
$179,212
|
|
Liver Disease
|
NIDDK
|
5F32DK074348-02
|
|
Hepatoxicity in an African HIV Treatment Cohort
|
HOFFMANN, CHRISTOPHER
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$53,992
|
|
Liver Disease
|
NIDA
|
1R01DA021550-01A2
|
|
HCV Transmission among Young IDUs in NYC
|
EDLIN, BRIAN
|
SUNY DOWNSTATE MEDICAL CENTER
|
NY
|
$834,452
|
|
Liver Disease
|
NIDDK
|
5R01DK061848-08
|
|
Immunodeficient mouse model of stem cell plasticity
|
NOLTA, JAN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$296,512
|
|
Liver Disease
|
NCCAM
|
1R21AT003195-01A2
|
|
Statin-Berberine Combination Therapy in Hyperlipidemia
|
LIU, JINGWEN
|
PALO ALTO INSTITUTE FOR RES & EDU, INC.
|
CA
|
$210,000
|
|
Liver Disease
|
NCCAM
|
1R21AT003833-01A1
|
|
Cruciferous Indoles in the Amelioration of the Metabolic Syndrome
|
THERIAULT, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$196,080
|
|
Liver Disease
|
NIGMS
|
5R01GM060620-09
|
|
Mechanism of RNA Helicase Activity by DExH/D Proteins
|
PYLE, ANNA
|
YALE UNIVERSITY
|
CT
|
$239,995
|
|
Liver Disease
|
NIEHS
|
5R01ES014626-02
|
|
Regulation of Sulfotransferases by LXR and its Implication in Pathophysiology
|
XIE, WEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$308,157
|
|
Liver Disease
|
NCI
|
5R01CA113797-03
|
|
Targeted Alpha-Particle Emitter Therapy of Metastases
|
SGOUROS, GEORGE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$278,677
|
|
Liver Disease
|
NCI
|
5R01CA040489-23
|
|
Pathogenesis of Hepatitis B Virus in Transgenic Mice
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$792,726
|
|
Liver Disease
|
NHLBI
|
2R01HL072304-06
|
|
Role of ABCG5 and ABCG8 in Sterol Metabolism
|
HOBBS, HELEN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$409,376
|
|
Liver Disease
|
NIAID
|
5R01AI047365-09
|
|
Structure and Function of the Hepatitis C Virus Genome
|
SARNOW, PETER
|
STANFORD UNIVERSITY
|
CA
|
$362,764
|
|
Liver Disease
|
NIAID
|
2R01AI020001-25
|
|
Pathogenesis of Liver Disease in Hepatitis
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$685,357
|
|
Liver Disease
|
NIAID
|
5R01AI064789-03
|
|
Nitric oxide and mitochondrial biogenesis in sepsis
|
PIANTADOSI, CLAUDE
|
DUKE UNIVERSITY
|
NC
|
$260,046
|
|
Liver Disease
|
NIDDK
|
5K08DK066040-05
|
|
Engineering Embryonic Stem Cell Differentiation into Hepatocytes
|
TILLES, ARNO
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$118,081
|
|
Liver Disease
|
NIDDK
|
5R01DK067416-04
|
|
Role of Lipolytic Enzymes in Intestinal Lipid Transport
|
HUI, DAVID
|
UNIVERSITY OF CINCINNATI
|
OH
|
$328,060
|
|
Liver Disease
|
NIEHS
|
5F32ES014777-02
|
|
Role of estrogen receptor beta in cancer prevention by dietary indole-3-carbinol
|
BENNINGHOFF, ABBY
|
OREGON STATE UNIVERSITY
|
OR
|
$24,398
|
|
Liver Disease
|
NIDDK
|
5K01DK065584-05
|
|
Regulation of Hepatic Metabolism by PGC-1 Coactivators
|
LIN, JIANDIE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$118,583
|
|
Liver Disease
|
NIMH
|
5R01MH067990-05
|
|
Fronto-Striatal Dysfunction in IFNa-Induced Depression
|
MILLER, ANDREW
|
EMORY UNIVERSITY
|
GA
|
$261,130
|
|
Liver Disease
|
NIAAA
|
5F31AA016710-02
|
|
Characterizing the role of peroxiredoxin 6 in Alcoholic Liver Disease.
|
ROEDE, JAMES
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$27,343
|
|
Liver Disease
|
NIMH
|
5K05MH069124-05
|
|
Pathology and Treatment of Cytokine-Induced Depression
|
MILLER, ANDREW
|
EMORY UNIVERSITY
|
GA
|
$116,932
|
|
Liver Disease
|
NIDDK
|
5R01DK065101-04
|
|
Intestinal ferroportin 1 expression and iron absorption
|
YEH, KWO-YIH
|
LOUISIANA STATE UNIV HSC SHREVEPORT
|
LA
|
$237,136
|
|
Liver Disease
|
NIDDK
|
5R01DK060764-05
|
|
HNF-4 and coactivators in apoAl gene regulation
|
MALIK, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
NY
|
$332,136
|
|
Liver Disease
|
NIAID
|
5R01AI064844-03
|
|
Role of Hepatitis B virus X protein in HBV replication.
|
BOUCHARD, MICHAEL
|
DREXEL UNIVERSITY
|
PA
|
$315,019
|
|
Liver Disease
|
NIDDK
|
5R01DK019514-28
|
|
Nutrient and Hormonal Regulations of AMPK and Malonyl CoA
|
RUDERMAN, NEIL
|
BOSTON MEDICAL CENTER
|
MA
|
$301,709
|
|
Liver Disease
|
NIDDK
|
5R01DK026919-27
|
|
Nutritional and Hormonal Regulation of Hepatic Genes
|
TOWLE, HOWARD
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$258,202
|
|
Liver Disease
|
NIEHS
|
5R01ES012752-05
|
|
Cellular Roles in Liver Pathology: Dioxin as Prototype
|
BRADFIELD, CHRISTOPHER
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$428,593
|
|
Liver Disease
|
NIGMS
|
5R01GM050441-14
|
|
Post-Traumatic Sepsis: Regulation of LPS Binding Protein
|
BILLIAR, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$264,958
|
|
Liver Disease
|
NIAID
|
5R01AI057591-04
|
|
Alteration of innate immunity by HCV core
|
HAHN, YOUNG
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$282,356
|
|
Liver Disease
|
NIEHS
|
5R01ES007800-12
|
|
Ah Receptor Anatomy: Implications for Dioxin Toxicity
|
ELFERINK, CORNELIS
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$330,706
|
|
Liver Disease
|
NHLBI
|
5R01HL037942-21
|
|
Purification & Characterization of Adenosine Receptors
|
LINDEN, JOEL
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$365,681
|
|
Liver Disease
|
NCI
|
5R01CA124648-02
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$419,084
|
|
Liver Disease
|
NIEHS
|
5R01ES013714-03
|
|
Coordinate Regulation of Uptake and Efflux Transporters
|
KLAASSEN, CURTIS
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$332,221
|
|
Liver Disease
|
NCI
|
5R01CA094076-07
|
|
ROLE OF ENZYME INDUCTION IN CANCER CHEMOPREVENTION
|
KENSLER, THOMAS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$412,459
|
|
Liver Disease
|
NIDDK
|
5R01DK066387-05
|
|
Modifiers of a Mouse Model of Alagille Syndrome
|
GRIDLEY, THOMAS
|
JACKSON LABORATORY
|
ME
|
$523,513
|
|
Liver Disease
|
NHLBI
|
5R01HL051586-15
|
|
Animal Models for Lipid Metabolism and Atherosclerosis
|
CHAN, LAWRENCE
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$364,125
|
|
Liver Disease
|
NIEHS
|
5R01ES012720-04
|
|
Gonadal vs. Genomic Influences on Xenobiotic Metabolism
|
VAN WINKLE, LAURA
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$234,813
|
|
Liver Disease
|
NIAID
|
5R37AI047367-09
|
|
HCV-specific T cell response
|
WALKER, CHRISTOPHER
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
OH
|
$541,702
|
|
Liver Disease
|
NIGMS
|
5R01GM053008-14
|
|
Modulation of Hepatocellular Function in Sepsis
|
WANG, PING
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$311,458
|
|
Liver Disease
|
NIDDK
|
5K01DK065635-06
|
|
Investigation of hepcidin in mammalian iron homeostasis
|
ROY, CINDY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$135,540
|
|
Liver Disease
|
NIDDK
|
5R01DK048252-15
|
|
Pathophysiology of Distal Tyrosine Pathway Disorders
|
GROMPE, MARKUS
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$308,500
|
|
Liver Disease
|
NICHD
|
8R01HD058299-26
|
|
Hepatic Drug Elimination in Pregnancy
|
VORE, MARY
|
UNIVERSITY OF KENTUCKY
|
KY
|
$330,211
|
|
Liver Disease
|
NIGMS
|
5R01GM041840-20
|
|
Copper Homeostasis in Yeast
|
THIELE, DENNIS
|
DUKE UNIVERSITY
|
NC
|
$318,324
|
|
Liver Disease
|
NIDDK
|
5F32DK067781-03
|
|
Cis- and Trans-acting Factors in HCV Gene Expression
|
BRADRICK, SHELTON
|
DUKE UNIVERSITY
|
NC
|
$52,048
|
|
Liver Disease
|
NIDDK
|
5R01DK061763-09
|
|
The Role of Copper in Pediatric Liver Disease
|
GITLIN, JONATHAN
|
WASHINGTON UNIVERSITY
|
MO
|
$275,100
|
|
Liver Disease
|
NIDDK
|
5R01DK038201-20
|
|
Regulation of sinusoidal perfusion in shock
|
CLEMENS, MARK
|
UNIVERSITY OF NORTH CAROLINA CHARLOTTE
|
NC
|
$215,604
|
|
Liver Disease
|
NIDDK
|
5R01DK063308-06
|
|
Regulation of Stellate Cell Contractility
|
ROCKEY, DON
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$342,836
|
|
Liver Disease
|
NINR
|
5R01NR009878-03
|
|
Adherence & Health Outcomes after Liver Transplantation
|
STILLEY, CAROL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$318,271
|
|
Liver Disease
|
NCI
|
5R01CA102325-04
|
|
cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma
|
WU, TONG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$224,802
|
|
Liver Disease
|
NIMH
|
5R01MH079752-02
|
|
Role of evolving white matter damage in neurocognitive effects of HIV and HCV
|
JERNIGAN, TERRY
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$347,625
|
|
Liver Disease
|
NHGRI
|
5F31HG004299-02
|
|
Genomic Approaches to Understanding Metabolism and Aging
|
CHAROS, ALEXANDRA
|
YALE UNIVERSITY
|
CT
|
$34,160
|
|
Liver Disease
|
NIEHS
|
5F31ES014113-02
|
|
4-nonylphenol alters P-450 expression in the liver.
|
HERNANDEZ, JUAN
|
UNIVERSITY OF TEXAS EL PASO
|
TX
|
$29,562
|
|
Liver Disease
|
NIDDK
|
5F31DK077578-02
|
|
Characterization of polyductin family proteins
|
SAMAROO, TIFFANY
|
YALE UNIVERSITY
|
CT
|
$26,272
|
|
Liver Disease
|
NIGMS
|
5R01GM065188-06
|
|
PINCH-1 Interactions and Functions
|
WU, CHUANYUE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$280,921
|
|
Liver Disease
|
NIAID
|
5R01AI072613-02
|
|
Identification and characterization of cellular factors involved in HCV entry
|
RICE, CHARLES
|
ROCKEFELLER UNIVERSITY
|
NY
|
$414,473
|
|
Liver Disease
|
NIAID
|
5R01AI067417-03
|
|
Molecular Modulation of HBV Capsid Assembly
|
ZLOTNICK, ADAM
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$345,885
|
|
Liver Disease
|
NIAID
|
5R01AI026522-30
|
|
Structure and Replication of Hepatitis Delta Virus
|
TAYLOR, JOHN
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$632,726
|
|
Liver Disease
|
NIAAA
|
5F31AA016434-02
|
|
Thioredoxin and ethanol-induced liver injury
|
COHEN, JESSICA
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$26,930
|
|
Liver Disease
|
NIDDK
|
5R01DK057539-08
|
|
Role of Forkhead Proteins in Insulin Action
|
ACCILI, DOMENICO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$395,522
|
|
Liver Disease
|
NIAID
|
5R01AI065985-03
|
|
Defining NS4B Function in Hepatitis C Virus Replication
|
BLIGHT, KERIL
|
WASHINGTON UNIVERSITY
|
MO
|
$289,575
|
|
Liver Disease
|
NIDDK
|
5R01DK064223-05
|
|
HCV NS5A: Molecular Virology and Antiviral Target
|
GLENN, JEFFREY
|
STANFORD UNIVERSITY
|
CA
|
$261,667
|
|
Liver Disease
|
NCI
|
5F32CA111040-03
|
|
Modulation of Hepatic N-Myristoyltransferases by Dioxins
|
WORMKE, MARK
|
NATL RESEARCH CTR/ENVIRONMENT & HEALTH
|
GERM
|
$45,048
|
|
Liver Disease
|
NIDDK
|
5R01DK049393-12
|
|
Exercise & Pioglitazone for HIV-Metabolic Syndromes
|
YARASHESKI, KEVIN
|
WASHINGTON UNIVERSITY
|
MO
|
$308,441
|
|
Liver Disease
|
NCI
|
5R01CA106280-04
|
|
Prostaglandin Signaling Pathway in Liver Cancer
|
WU, TONG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$224,802
|
|
Liver Disease
|
NIMH
|
5R01MH070553-04
|
|
Cytokine-CRH Interactions in IFN-alfa-Induced Depression
|
RAISON, CHARLES
|
EMORY UNIVERSITY
|
GA
|
$326,412
|
|
Liver Disease
|
NIGMS
|
5R01GM031555-25
|
|
Factors in the Prevention of Toxic Liver Injury
|
BOYER, THOMAS
|
UNIVERSITY OF ARIZONA
|
AZ
|
$343,622
|
|
Liver Disease
|
NIAID
|
5R01AI020720-25
|
|
Mechanisms of Chronic Hepatitis B Infection and Therapeutic Vaccines
|
MILICH, DAVID
|
VACCINE RESEARCH INSTITUTE OF SAN DIEGO
|
CA
|
$747,395
|
|
Liver Disease
|
NIDDK
|
5R01DK064366-05
|
|
A Promoter-Specific TFO Prevents Liver Fibrosis
|
GUNTAKA, RAMAREDDY
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$268,618
|
|
Liver Disease
|
NICHD
|
5R01HD035831-09
|
|
Nutritional Regulation of Fetal Liver Development
|
GRUPPUSO, PHILIP
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$225,382
|
|
Liver Disease
|
NIGMS
|
5R01GM076343-03
|
|
Structural Basis of Cytochrome P450 2A13 Activity
|
SCOTT, EMILY
|
UNIVERSITY OF KANSAS LAWRENCE
|
KS
|
$270,737
|
|
Liver Disease
|
NIAAA
|
5R01AA007846-18
|
|
Effects of Ethanol on Endocytosis in the Liver
|
CASEY, CAROL
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$215,048
|
|
Liver Disease
|
NHLBI
|
5R01HL078817-04
|
|
Differential Regulation of SR-B Isoforms by Estrogen
|
MC LEAN, MARK
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$341,843
|
|
Liver Disease
|
NCI
|
5R21CA116525-02
|
|
Design of targeted native tropism-ablated adenovirus
|
DMITRIEV, IGOR
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$145,500
|
|
Liver Disease
|
NIDDK
|
5R01DK073462-02
|
|
Iron Lipcalin In Kidney Disease
|
BARASCH, JONATHAN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$326,198
|
|
Liver Disease
|
NHLBI
|
5R01HL050710-14
|
|
Regulation of Hepatic P450s by Anti-Cholesterol Drugs
|
KOCAREK, THOMAS
|
WAYNE STATE UNIVERSITY
|
MI
|
$286,350
|
|
Liver Disease
|
NIDDK
|
5R01DK058614-07
|
|
Mechanisms of oval cell activation and differentiation
|
PETERSEN, BRYON
|
UNIVERSITY OF FLORIDA
|
FL
|
$246,791
|
|
Liver Disease
|
NIAAA
|
5K01AA015577-03
|
|
Alcohol & FAS-Mediated Apoptosis in Polarized Liver Cell
|
MCVICKER, BENITA
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$109,781
|
|
Liver Disease
|
NIGMS
|
5R01GM063115-06
|
|
Role of the Acetyl-CoA Carboxylases in Energy Metabolism
|
WAKIL, SALIH
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$460,697
|
|
Liver Disease
|
NIDDK
|
5R37DK027619-24
|
|
Quantitative Studies of Metabolic Organ Dynamics
|
BERGMAN, RICHARD
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$518,006
|
|
Liver Disease
|
NIDDK
|
5R01DK062277-05
|
|
Role of Wnt/Beta-Catenin Signaling in Liver Development
|
MONGA, SATDARSHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$218,911
|
|
Liver Disease
|
NIAID
|
5R37AI028731-19
|
|
Noncarbohydrate Approaches to AntiAIDS Nuleosides
|
LIOTTA, DENNIS
|
EMORY UNIVERSITY
|
GA
|
$324,651
|
|
Liver Disease
|
NIDDK
|
5R01DK066266-05
|
|
Long-term Outcome: Transplant for Alcohol Liver Disease
|
DIMARTINI, ANDREA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$259,419
|
|
Liver Disease
|
NIAID
|
5R01AI061158-04
|
|
Mechanisms of Innate and Adaptive Immunity In HCV
|
NELSON, DAVID
|
UNIVERSITY OF FLORIDA
|
FL
|
$304,514
|
|
Liver Disease
|
NCI
|
5R01CA039416-23
|
|
Molecular Mechanisms of Chemoprevention: Dithiolethiones
|
KENSLER, THOMAS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$502,144
|
|
Liver Disease
|
NIDDK
|
5R01DK025836-24
|
|
Function and Expression of the Bile Acid Transport Protein m-Epoxide Hydrolase
|
LEVY, DANIEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$286,174
|
|
Liver Disease
|
NIDDK
|
5R01DK025541-31
|
|
Hormonal Regulation of Enzyme Levels in Mammalian Tissue
|
HANSON, RICHARD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$300,691
|
|
Liver Disease
|
NIA
|
5R01AG027973-02
|
|
Role of ABCA1 in neurodegeneration
|
KOLDAMOVA, RADOSVETA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$253,942
|
|
Liver Disease
|
NIDDK
|
5R01DK056966-06
|
|
Role of Tissue Micro-Architecture on Hepatocyte Function
|
BHATIA, SANGEETA
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$342,972
|
|
Liver Disease
|
NCI
|
5R01CA083650-09
|
|
ALTERED GROWTH FACTOR PATHWAYS IN BILIARY CANCER
|
SIRICA, ALPHONSE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$302,232
|
|
Liver Disease
|
NIGMS
|
5R01GM057463-09
|
|
Lipoproteins Modulate the Hepatic Response to Endotoxin
|
HARRIS, HOBART
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$305,255
|
|
Liver Disease
|
NIDDK
|
5K08DK076845-02
|
|
Growth Regulatory Mechanisms of KLF in Barrett's Epithelium
|
BUTTAR, NAVTEJ
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$127,224
|
|
Liver Disease
|
NIDDK
|
5R01DK065056-05
|
|
Analysis of ARPKD by Targeted Manipulation of Pkhd1
|
WARD, CHRISTOPHER
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$271,378
|
|
Liver Disease
|
NIAID
|
5R21AI067449-02
|
|
Prevalence and Epidemiology of Hepatitis E Virus in the United States
|
NELSON, KENRAD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$105,948
|
|
Liver Disease
|
NHLBI
|
5R21HL081892-02
|
|
Subharmonic Microbubble Signals for Pressure Estimation
|
FORSBERG, FLEMMING
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$206,200
|
|
Liver Disease
|
NIDDK
|
5R01DK058763-08
|
|
Human Se Nutritional Requirement and Biomarkers in Health and Disease
|
BURK, RAYMOND
|
VANDERBILT UNIVERSITY
|
TN
|
$411,490
|
|
Liver Disease
|
NIAID
|
5R01AI043453-11
|
|
Mechanisms of Hepadnavirus Assembly and Replication
|
HU, JIANMING
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$297,279
|
|
Liver Disease
|
NIDDK
|
5R01DK066336-06
|
|
Molecular Physiology of Liver Fatty Acid Transporters
|
STAHL, ANDREAS
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$248,584
|
|
Liver Disease
|
NIDDK
|
5R01DK032034-27
|
|
PORPHYRIN AND CORRINOID BIOSYNTHESIS
|
RAUSHEL, FRANK
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$519,698
|
|
Liver Disease
|
NICHD
|
5K08HD048867-04
|
|
PLACENTAL CARNITINE: ROLE IN FETAL DEVELOPMENT
|
SHEKHAWAT, PREM
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$28,688
|
|
Liver Disease
|
NIAAA
|
5R01AA014891-04
|
|
NFkB-mediated collagen regulation by SAMe in HSCs
|
SCHRUM, LAURA
|
UNIVERSITY OF NORTH CAROLINA CHARLOTTE
|
NC
|
$197,874
|
|
Liver Disease
|
NIAID
|
5R21AI072170-02
|
|
Roles of host RNA binding proteins in virus replication
|
NAGY, PETER
|
UNIVERSITY OF KENTUCKY
|
KY
|
$200,124
|
|
Liver Disease
|
NIDDK
|
5R01DK068463-04
|
|
Intralumental Effect on Cholesterol Absorption/Synthesis
|
HEUBI, JAMES
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$457,731
|
|
Liver Disease
|
NIAID
|
5R01AI069000-03
|
|
Roles for microRNA-122 in hepatitis C virus RNA amplification
|
SARNOW, PETER
|
STANFORD UNIVERSITY
|
CA
|
$295,433
|
|
Liver Disease
|
NIAID
|
5R01AI030070-16
|
|
Regulation of Hepatitis B Virus Transcription
|
MCLACHLAN, ALAN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$512,408
|
|
Liver Disease
|
NIDDK
|
5R01DK045943-11
|
|
EFFECTS OF IKKB and NFkB IN INSULIN RESISTANCE
|
SHOELSON, STEVEN
|
JOSLIN DIABETES CENTER
|
MA
|
$362,489
|
|
Liver Disease
|
NCI
|
5R01CA023931-30
|
|
Analyzing Hepatitis B Virus Pathogenesis
|
ISOM, HARRIET
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$325,985
|
|
Liver Disease
|
NCI
|
5R01CA100908-04
|
|
Role of Kupffer Cell in Hepatic Carcinogenesis
|
KLAUNIG, JAMES
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$226,529
|
|
Liver Disease
|
NIDDK
|
1R01DK079806-01
|
|
High Throughput Genetic and Drug Screens for Alph-1-Antitrypsin Deficiency
|
SILVERMAN, GARY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$540,159
|
|
Liver Disease
|
NIAID
|
5U01AI064002-04
|
|
Chemoprophylaxis for HIV Prevention in Men
|
GRANT, ROBERT
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$5,141,967
|
|
Liver Disease
|
NIDDK
|
5R25DK066028-05
|
|
Undergraduate Training in Gastrointestinal Sciences
|
KATZ, JONATHAN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$88,152
|
|
Liver Disease
|
NIBIB
|
5K08EB004348-04
|
|
Percutaneous MR Guided Creation of a Meso-Caval Shunt
|
AREPALLY, ARAVIND
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$193,361
|
|
Liver Disease
|
NIAID
|
5R01AI059714-05
|
|
Immune Tolerance in Non-Clonal Immune Systems
|
NEMAZEE, DAVID
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$352,533
|
|
Liver Disease
|
NIDDK
|
5K08DK069621-04
|
|
Mechanisms of Hepatic Steatosis Prevention
|
PUDER, MARK
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$127,683
|
|
Liver Disease
|
NIDDK
|
5R01DK047416-12
|
|
Nutrient Effects on Insulin Action
|
PAGLIASSOTTI, MICHAEL
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$227,803
|
|
Liver Disease
|
NIDDK
|
5R01DK076729-02
|
|
De Novo Lipogenesis and Metabolic Disease
|
SEMENKOVICH, CLAY
|
WASHINGTON UNIVERSITY
|
MO
|
$305,368
|
|
Liver Disease
|
NICHD
|
5R01HD046949-05
|
|
Copper Transport in Lactation
|
LINDER, MARIA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
CA
|
$232,056
|
|
Liver Disease
|
NIGMS
|
5K08GM074238-03
|
|
Function and Evolution of the Pregnane X Receptor (PXR)
|
KRASOWSKI, MATTHEW
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$127,305
|
|
Liver Disease
|
NHLBI
|
5R01HL068703-06
|
|
Therapeutic Use of Heme Analogs: Absorption in Intestine
|
STEVENSON, DAVID
|
STANFORD UNIVERSITY
|
CA
|
$235,623
|
|
Liver Disease
|
NIDDK
|
5R01DK054254-08
|
|
CEACAM AND INSULIN ACTION
|
NAJJAR, SONIA
|
UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
|
OH
|
$303,167
|
|
Liver Disease
|
NIDDK
|
5R01DK067233-05
|
|
Thyroid Hormone Receptor Isoform-Specific Actions
|
BRENT, GREGORY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$269,287
|
|
Liver Disease
|
NIAID
|
5R01AI069142-02
|
|
Immune Mechanisms of HCV Persistence and Pathogenesis
|
SUN, JIAREN
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$333,295
|
|
Liver Disease
|
NCI
|
5R01CA076183-06
|
|
Targeting diffuse liver metastases with Herpes virus
|
TANABE, KENNETH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$375,113
|
|
Liver Disease
|
NIDA
|
5R01DA011598-10
|
|
Nutritional Status In HIV Hispanic Drug Abusers
|
FORRESTER, JANET
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$660,216
|
|
Liver Disease
|
NCI
|
5R01CA114403-03
|
|
Biliary oxysterols and cholangiocarcinoma
|
KUVER, RAHUL
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
WA
|
$212,356
|
|
Liver Disease
|
NIEHS
|
1R01ES015241-01A1
|
|
Bioengineering partnership to improve chemical hazard testing paradigms
|
RUSYN, IVAN
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$496,306
|
|
Liver Disease
|
NHLBI
|
5R01HL087228-02
|
|
GHIHBP1 and the Metabolism of Triglyceride-Rich Lipoproteins
|
YOUNG, STEPHEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$347,250
|
|
Liver Disease
|
NIDDK
|
5F32DK077380-02
|
|
Mechanisms of Nitrite Mediated Hepatic Preconditioning: Role of the Mitochondria
|
CALVERT, JOHN
|
YESHIVA UNIVERSITY
|
NY
|
$28,462
|
|
Liver Disease
|
NIDDK
|
5K08DK069765-04
|
|
Apoptosis and Liver Fibrogenesis
|
TOROK, NATALIE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$124,549
|
|
Liver Disease
|
NIDDK
|
5R01DK047918-14
|
|
Keratin Biology and Disease Aspects in Simple Epithelia
|
OMARY, M
|
STANFORD UNIVERSITY
|
CA
|
$109,205
|
|
Liver Disease
|
NIDDK
|
7R01DK066373-05
|
|
Modifiers of Iron Loading in Mice
|
ANDREWS, NANCY
|
DUKE UNIVERSITY
|
NC
|
$419,833
|
|
Liver Disease
|
NIAID
|
5R01AI066208-02
|
|
Bile, Biofilms and Salmonella Gallbladder Carriage
|
GUNN, JOHN
|
OHIO STATE UNIVERSITY
|
OH
|
$361,376
|
|
Liver Disease
|
NCI
|
5R37CA023226-37
|
|
GENE EXPRESSION IN REGENERATING AND NEOPLASTIC LIVERS
|
FAUSTO, NELSON
|
UNIVERSITY OF WASHINGTON
|
WA
|
$378,690
|
|
Liver Disease
|
NCRR
|
1R21RR024439-01
|
|
Development of a parallel, array-based transcription factor expression assay
|
WALTON, STEPHEN
|
MICHIGAN STATE UNIVERSITY
|
MI
|
$180,855
|
|
Liver Disease
|
NIGMS
|
5R21GM077501-02
|
|
Automated analysis of NKT cell sentry pattern in liver with metastatic tumor
|
CLEMENS, MARK
|
UNIVERSITY OF NORTH CAROLINA CHARLOTTE
|
NC
|
$144,000
|
|
Liver Disease
|
NIDDK
|
5R01DK067440-04
|
|
Viral Immunoregulatory Genes and Hepatocyte Transplants
|
ROY-CHOWDHURY, JAYANTA
|
YESHIVA UNIVERSITY
|
NY
|
$341,395
|
|
Liver Disease
|
NIA
|
5R01AG026711-02
|
|
Role of Neutral Sphingomyelinase-2 in aging
|
NIKOLOVA-KARAKASHIAN, MARIANA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$294,319
|
|
Liver Disease
|
NIDDK
|
5R01DK071125-02
|
|
Anti-inflammatory Properties of Bilirubin
|
ZUCKER, STEPHEN
|
UNIVERSITY OF CINCINNATI
|
OH
|
$250,723
|
|
Liver Disease
|
NIDDK
|
5R01DK013499-39
|
|
Regulation of Liver Growth and Function
|
JEFFERSON, LEONARD
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$432,352
|
|
Liver Disease
|
NIAAA
|
5R01AA010435-11
|
|
Alcohol and Liver Endothelial Cells in Immune Responses
|
THIELE, GEOFFREY
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
NE
|
$283,500
|
|
Liver Disease
|
NIDDK
|
1R01DK080003-01
|
|
The Central Melanocortin System and Regulation of Energy Balance
|
WARDLAW, SHARON
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$342,125
|
|
Liver Disease
|
NCI
|
5R01CA111355-04
|
|
Low birth weight & other risk factors for hepatoblastoma
|
SPECTOR, LOGAN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$492,347
|
|
Liver Disease
|
NIDDK
|
5R01DK054208-08
|
|
Bile Acid Modulation of Bile Duct Secretion and Growth
|
LESAGE, GENE
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$298,337
|
|
Liver Disease
|
NIEHS
|
1R01ES016313-01
|
|
The Environment as a Variable to Calibrate Mouse Models of Human Disease
|
ESSIGMANN, JOHN
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$544,391
|
|
Liver Disease
|
NIDDK
|
5R01DK055710-07
|
|
The plasminogen system and liver repair
|
BEZERRA, JORGE
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$301,350
|
|
Liver Disease
|
NIDDK
|
1R01DK080440-01
|
|
SHP-regulation of Lipid and Lipoprotein Metabolism
|
WANG, LI
|
UNIVERSITY OF UTAH
|
UT
|
$263,375
|
|
Liver Disease
|
NHLBI
|
5R21HL086828-02
|
|
R21: Entrainment of Peripheral Circadian Rhythms
|
BITTMAN, ERIC
|
UNIVERSITY OF MASSACHUSETTS AMHERST
|
MA
|
$193,146
|
|
Liver Disease
|
NIEHS
|
5R01ES014403-03
|
|
PAHs: Balance of Detoxication vs Metabolic Activation
|
NEBERT, DANIEL
|
UNIVERSITY OF CINCINNATI
|
OH
|
$337,830
|
|
Liver Disease
|
NIA
|
5R01AG028158-02
|
|
Mechanism and structural basis of amyloid fibril formation by serum amyloid A
|
COLON, WILFREDO
|
RENSSELAER POLYTECHNIC INSTITUTE
|
NY
|
$210,547
|
|
Liver Disease
|
NIDDK
|
5R01DK044234-15
|
|
Modulation of Acute Liver Injury
|
CZAJA, MARK
|
YESHIVA UNIVERSITY
|
NY
|
$366,030
|
|
Liver Disease
|
NIMH
|
5K23MH071177-04
|
|
Adherence to HCV Treatment in HCV and HCV/HIV Patients
|
WEISS, JEFFREY
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$148,791
|
|
Liver Disease
|
NCI
|
5R01CA042857-20
|
|
Metastatic Potential of Colorectal Carcinoma
|
MISHRA, LOPA
|
GEORGETOWN UNIVERSITY
|
DC
|
$297,866
|
|
Liver Disease
|
NICHD
|
5R01HD052682-02
|
|
Control of Breathing & Glycogen Storage Disease
|
FULLER, DAVID
|
UNIVERSITY OF FLORIDA
|
FL
|
$305,086
|
|
Liver Disease
|
NCI
|
5R01CA056533-16
|
|
Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis
|
SCHNEIDER, ROBERT
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$423,021
|
|
Liver Disease
|
NIDDK
|
2R01DK059615-06A1
|
|
Molecular Mechanisms of Portal Hypertension
|
SHAH, VIJAY
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$321,088
|
|
Liver Disease
|
NIAID
|
2R01AI050611-05A2
|
|
A Chicken Model to Study Hepatitis E Virus Pathogenesis
|
MENG, XIANG-JIN
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
VA
|
$315,867
|
|
Liver Disease
|
NCI
|
5R01CA115625-02
|
|
Proteomic Analysis of Serum in Liver Cancer
|
GOLDMAN, RADOSLAV
|
GEORGETOWN UNIVERSITY
|
DC
|
$340,569
|
|
Liver Disease
|
NIAID
|
5R01AI060018-04
|
|
Mechanisms of Avian Hepadnavirus Replication
|
LOEB, DANIEL
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$332,989
|
|
Liver Disease
|
NIBIB
|
5R01EB003922-02
|
|
Targeted Delivery of TFOs for Treatment of Liver Fibrosis
|
MAHATO, RAM
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$225,351
|
|
Liver Disease
|
NIDDK
|
5K01DK071538-03
|
|
Cell Biology of Human Vit C Transporters in Liver Cells
|
SUBRAMANIAN, VEEDAMALI
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$126,900
|
|
Liver Disease
|
NIDDK
|
5R03DK072215-02
|
|
Regulating Hepatic Progenitor Cell Proliferation
|
GERBER, DAVID
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$71,540
|
|
Liver Disease
|
NIAAA
|
5R01AA014418-05
|
|
KILLER CELLS AND ALCOHOL
|
BALLAS, ZUHAIR
|
UNIVERSITY OF IOWA
|
IA
|
$268,810
|
|
Liver Disease
|
NIAID
|
1R21AI076706-01
|
|
Impact of NK Cell Immune Pressures on HCV Evolution and Viral Fitness
|
ALTFELD, MARCUS
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$263,250
|
|
Liver Disease
|
NIDDK
|
2R01DK063947-06
|
|
Organelle Dysfunction and Apoptosis in Liver Epithelia
|
GORES, GREGORY
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$288,979
|
|
Liver Disease
|
NIEHS
|
1R03ES016368-01
|
|
Effects of Personal Exposure to Volatile Organic Compounds on Liver Function
|
WU, TIEJIAN
|
EAST TENNESSEE STATE UNIVERSITY
|
TN
|
$71,000
|
|
Liver Disease
|
NIDDK
|
5R03DK077707-02
|
|
Early Detection and Prognosis of Patients with Hepatocellular Carcinoma
|
MARRERO, JORGE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$74,480
|
|
Liver Disease
|
NIDDK
|
5R01DK072749-02
|
|
Liver Vs Bone PAH Metabolism: Synergy with TNF in Bone
|
JEFCOATE, COLIN
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$297,010
|
|
Liver Disease
|
NIDDK
|
5R01DK076852-02
|
|
The Lysosomal-Mitochondrial Axis in Nonalcoholic Fatty Liver Disease
|
FELDSTEIN, ARIEL
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$279,351
|
|
Liver Disease
|
NIDDK
|
1K01DK080241-01
|
|
Gene Network Based Differentiation of Stem Cells in a Microfabricated Array
|
NAHMIAS, YAAKOV
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$129,060
|
|
Liver Disease
|
NIDDK
|
1K23DK080145-01
|
|
Analysis of Fatty Liver in the Framingham Heart Study Cohort
|
SPELIOTES, ELIZABETH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$185,544
|
|
Liver Disease
|
NIAID
|
1R21AI076834-01
|
|
Cell Culture System for Hepatitis C Virus Genotype 1a
|
DI BISCEGLIE, ADRIAN
|
SAINT LOUIS UNIVERSITY
|
MO
|
$183,750
|
|
Liver Disease
|
NIDDK
|
5K24DK070528-04
|
|
Mentorship in Liver Disease
|
SHERMAN, KENNETH
|
UNIVERSITY OF CINCINNATI
|
OH
|
$117,084
|
|
Liver Disease
|
NIAID
|
2R01AI051390-07A1
|
|
Immunology of Factor IX Gene Transfer to Liver
|
HERZOG, ROLAND
|
UNIVERSITY OF FLORIDA
|
FL
|
$325,028
|
|
Liver Disease
|
NCI
|
5R01CA109733-04
|
|
Molecular Target(s) for Interruption of HBV Infection
|
LI, JISU
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$214,052
|
|
Liver Disease
|
NIDDK
|
5R01DK070858-02
|
|
Molecular Basis of Liver Development
|
ZORN, AARON
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$301,350
|
|
Liver Disease
|
NIA
|
5R01AG029148-02
|
|
Hepcidin and the pathogenesis of anemia in older adults.
|
SEMBA, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$297,468
|
|
Liver Disease
|
NCI
|
5R37CA081301-10
|
|
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
|
HECHT, STEPHEN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$477,962
|
|
Liver Disease
|
NIEHS
|
1R01ES013781-01A2
|
|
Mechanisms for Arsenic-Induced Vascular Disease
|
BARCHOWSKY, AARON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$328,179
|
|
Liver Disease
|
NCI
|
5R01CA121171-03
|
|
Molecular mediators of metastasis in hepatocellular carcinoma
|
LEWIS, BRIAN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$280,074
|
|
Liver Disease
|
NIAID
|
5R01AI058740-05
|
|
GB Virus type C Natural History, Epidemiology, HIV Interaction
|
STAPLETON, JACK
|
UNIVERSITY OF IOWA
|
IA
|
$617,141
|
|
Liver Disease
|
NIAID
|
5R01AI065981-02
|
|
Iron and pathogenesis in infections by Vibrio vulnificus
|
CROSA, JORGE
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$377,685
|
|
Liver Disease
|
NIAID
|
5R21AI067455-02
|
|
Resolution of Acute Hepatitis B Virus Infections in Chimpanzees
|
LANFORD, ROBERT
|
SOUTHWEST FOUNDATION FOR BIOMEDICAL RES
|
TX
|
$222,579
|
|
Liver Disease
|
NIDDK
|
5R01DK051592-11
|
|
Transplantation Assay for Liver Repopulating Cells
|
GROMPE, MARKUS
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$307,821
|
|
Liver Disease
|
NIDDK
|
1R01DK078184-01A1
|
|
Factors Controlling Metabolic Flux in the Liver by NMR Isotopomer Analysis
|
BURGESS, SHAWN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$314,000
|
|
Liver Disease
|
NCI
|
2R01CA058073-15A1
|
|
Molecular Mechanisms of Growth Control in Prostate Cancer
|
LIAO, SHUTSUNG
|
UNIVERSITY OF CHICAGO
|
IL
|
$315,168
|
|
Liver Disease
|
NIDDK
|
2R01DK056644-06A2
|
|
Mechanisms of Cell Volume Regulation in Liver
|
LIDOFSKY, STEVEN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$319,990
|
|
Liver Disease
|
NIAID
|
5R01AI069285-02
|
|
Role of TLR3 Signaling in Control of HCV
|
LI, KUI
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$126,887
|
|
Liver Disease
|
NCI
|
5R03CA119313-02
|
|
Novel Machine Learning Methods for Analysis of MALDI-TOF Mass Spectrometry Data
|
RESSOM, HABTOM
|
GEORGETOWN UNIVERSITY
|
DC
|
$77,600
|
|
Liver Disease
|
NCI
|
5R01CA076541-10
|
|
Liver Regeneration as a Model for Angiogenesis
|
STOLZ, DONNA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$220,307
|
|
Liver Disease
|
NCI
|
5R01CA103958-05
|
|
HGF and Signaling Pathways in Hepatic Tissue Assembly
|
MICHALOPOULOS, GEORGE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$282,995
|
|
Liver Disease
|
NIDDK
|
5R01DK066939-05
|
|
Modulation of HCV Gene Expression
|
BRANCH, ANDREA
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$370,132
|
|
Liver Disease
|
NIDDK
|
5R01DK070877-03
|
|
Immunoglobulin Allotypes in Hepatitis C Virus Infection
|
PANDEY, JANARDAN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
SC
|
$186,896
|
|
Liver Disease
|
NIDDK
|
5R01DK055743-08
|
|
Transcriptional Regulation of Mammalian Hepatic Development
|
DUNCAN, STEPHEN
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$345,994
|
|
Liver Disease
|
NIDDK
|
5R01DK066802-05
|
|
PATHOPHYSIOLOGY OF CRYOGLOBULINEMIC GLOMERULONEPHRITIS
|
ALPERS, CHARLES
|
UNIVERSITY OF WASHINGTON
|
WA
|
$352,173
|
|
Liver Disease
|
NIDDK
|
5K01DK073032-03
|
|
Liver SVCT Systems: Vitamin C Uptake, Roles & Regulation
|
REIDLING, JACK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$126,900
|
|
Liver Disease
|
NIDDK
|
5R01DK023026-30
|
|
HEPATIC ORGANIC ANION UPTAKE TRANSPORT
|
WOLKOFF, ALLAN
|
YESHIVA UNIVERSITY
|
NY
|
$436,640
|
|
Liver Disease
|
NIAAA
|
5R01AA015752-02
|
|
Intracellular Therapeutics for Inflammatory Liver Injury
|
HAWIGER, JACK
|
VANDERBILT UNIVERSITY
|
TN
|
$345,375
|
|
Liver Disease
|
NIDDK
|
2R01DK064008-05
|
|
Immunologic Dysfunction in Biliary Atresia
|
BEZERRA, JORGE
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$318,750
|
|
Liver Disease
|
NIDDK
|
5R01DK050574-13
|
|
Pathogenesis of Hepatic Fibrosis and Portal Hypertension
|
ROCKEY, DON
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$314,127
|
|
Liver Disease
|
NIEHS
|
5R01ES012018-04
|
|
Ah Receptor Action and Apoptosis
|
ELFERINK, CORNELIS
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$299,918
|
|
Liver Disease
|
NIEHS
|
5R01ES012265-05
|
|
Role and Regulation of INrf2
|
JAISWAL, ANIL
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$331,034
|
|
Liver Disease
|
NIDDK
|
5K01DK067207-04
|
|
Genetic Epidemiology of NAFLD and T2DM
|
KAO, WEN HONG
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$128,958
|
|
Liver Disease
|
NIDDK
|
5R01DK056886-09
|
|
The role of the Akt/PKB signaling in insulin action
|
BIRNBAUM, MORRIS
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$347,236
|
|
Liver Disease
|
NIDDK
|
5R01DK075415-02
|
|
Differentiating Human ESC Towards Hepatocytes
|
ZERN, MARK
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$297,000
|
|
Liver Disease
|
NIAID
|
5R01AI069952-03
|
|
Statistical methods for modeling hepatitis C fibrosis progression
|
BACCHETTI, PETER
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$178,477
|
|
Liver Disease
|
NIDDK
|
5R01DK051041-11
|
|
Genetics of Autosomal Dominant Polycystic Liver Disease
|
SOMLO, STEFAN
|
YALE UNIVERSITY
|
CT
|
$458,671
|
|
Liver Disease
|
NIDDK
|
5R01DK053761-09
|
|
REGULATION OF 15N UREA ISOTOPOMERS PRODUCTION
|
NISSIM, ITZHAK
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$349,154
|
|
Liver Disease
|
NIDDK
|
5R01DK068097-03
|
|
Neutrophil-macrophage Interactions Govern Liver Immunity
|
GREGORY, STEPHEN
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$256,926
|
|
Liver Disease
|
NCI
|
5R01CA083817-08
|
|
Signal integration of the death receptor pathways
|
YIN, XIAO-MING
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$218,579
|
|
Liver Disease
|
NIDDK
|
1R01DK073917-01A2
|
|
The Role of Dysfunctional CCK-1R in Cholelithogenesis
|
WANG, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$361,250
|
|
Liver Disease
|
NHLBI
|
5R01HL073921-05
|
|
Pathophysiology of IFN-alpha-induced Sleep Disturbances
|
MILLER, ANDREW
|
EMORY UNIVERSITY
|
GA
|
$290,143
|
|
Liver Disease
|
NCI
|
5R01CA102575-04
|
|
Mechanism of gallbladder tumorigenesis in BK5.erbB2 mice
|
KIGUCHI, KAORU
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$224,720
|
|
Liver Disease
|
NIDDK
|
5F32DK074320-02
|
|
Novel Functions of D-type Cyclins in Hepatocytes
|
MULLANY, LISA
|
MINNEAPOLIS MEDICAL RESEARCH FDN, INC.
|
MN
|
$50,428
|
|
Liver Disease
|
NIDDK
|
5R01DK068575-04
|
|
Regulation of Renal Cortical Adenosine Levels
|
JACKSON, EDWIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$323,004
|
|
Liver Disease
|
NIDDK
|
5R44DK064469-03
|
|
A new hepatocyte-specific ligand for gene delivery
|
WONG, SO
|
MIRUS BIO CORPORATION
|
WI
|
$617,364
|
|
Liver Disease
|
NIDDK
|
5T32DK007745-12
|
|
UT GASTROENTEROLOGY/HEPATOLOGY RESEARCH TRAINING PROGRAM
|
DIETSCHY, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$242,590
|
|
Liver Disease
|
NHLBI
|
5R01HL082697-03
|
|
SR-B1 Sorting Signals in HDL Metabolism
|
SILVER, DAVID
|
YESHIVA UNIVERSITY
|
NY
|
$282,076
|
|
Liver Disease
|
NCI
|
1R01CA126807-01A1
|
|
HCV genetic variation and hepatocellular carcinoma
|
TAVIS, JOHN
|
SAINT LOUIS UNIVERSITY
|
MO
|
$274,523
|
|
Liver Disease
|
NCI
|
5R37CA090426-08
|
|
Metabolism of Carcinogens and Drugs by Human P450s
|
GUENGERICH, F
|
VANDERBILT UNIVERSITY
|
TN
|
$353,556
|
|
Liver Disease
|
NIAID
|
5R01AI057189-05
|
|
HIV Protease Inhibitors and Hepatic Lipid Dysregulation
|
HYLEMON, PHILLIP
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$308,676
|
|
Liver Disease
|
NIDDK
|
2R01DK059368-05A1
|
|
Regulation of metabolic gene expression
|
PARK, EDWARDS
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$279,225
|
|
Liver Disease
|
NIAAA
|
2R01AA012897-07A1
|
|
Effects of Ethanol TNF Induced Cytotoxicity
|
PASTORINO, JOHN
|
UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED
|
NJ
|
$259,350
|
|
Liver Disease
|
NCI
|
1R01CA122539-01A2
|
|
Lymphoproliferative Disorders in Primary Immunodeficiencies
|
ROUTES, JOHN
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$314,363
|
|
Liver Disease
|
NIDDK
|
2R01DK033765-25
|
|
Cytochrome P450-Endogenous Substrate Metabolism
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY
|
MA
|
$445,250
|
|
Liver Disease
|
NIDDK
|
5R01DK056669-07
|
|
Transcriptional control in hepatocyte proliferation
|
GREENBAUM, LINDA
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$316,418
|
|
Liver Disease
|
NCI
|
5R01CA100882-05
|
|
Molecular Pathogenesis of Hepatocellular Carcinoma
|
ROBERTS, LEWIS
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$258,035
|
|
Liver Disease
|
NIAAA
|
5R01AA013395-07
|
|
Ethanol Hepatotoxicity and NO-Dependent Mitochondrial Dysfunction
|
DARLEY-USMAR, VICTOR
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$294,638
|
|
Liver Disease
|
NIAID
|
5R01AI068090-03
|
|
Understanding Immunopathogenesis of Hepatitis B Virus
|
BARON, JODY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$367,527
|
|
Liver Disease
|
NIDDK
|
1R01DK073897-01A2
|
|
Iron-Induced Changes in Liver That Predispose to Malignancy
|
ISOM, HARRIET
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$245,493
|
|
Liver Disease
|
NIAID
|
2R01AI018188-27A1
|
|
Interactions of Endotoxin with Plasma and Cells
|
MUNFORD, ROBERT
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$447,864
|
|
Liver Disease
|
NIDDK
|
2R01DK047618-20
|
|
Adiponectin and CTRP9 signaling in muscle and liver
|
LODISH, HARVEY
|
WHITEHEAD INSTITUTE FOR BIOMEDICAL RES
|
MA
|
$704,872
|
|
Liver Disease
|
NIDDK
|
2R01DK056598-23
|
|
Metabolism of Glycerolipids in Liver
|
COLEMAN, ROSALIND
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$312,375
|
|
Liver Disease
|
NIDDK
|
1R01DK078187-01A1
|
|
LIPIN 1 IN THE REGULATION OF HEPATIC LIPID METABOLISM
|
FINCK, BRIAN
|
WASHINGTON UNIVERSITY
|
MO
|
$304,000
|
|
Liver Disease
|
NIA
|
1R01AG030027-01A1
|
|
Aging and the Tissue Response to Misfolded Proteins
|
BUXBAUM, JOEL
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$388,475
|
|
Liver Disease
|
NIDDK
|
1R01DK075990-01A2
|
|
Nutrition and Nonalcoholic Fatty Liver Disease
|
LI, ZHIPING
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$348,500
|
|
Liver Disease
|
NIDDK
|
1R01DK074821-01A2
|
|
CYP4F3 in renal inflammation
|
CHRISTMAS, PETER
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$371,299
|
|
Liver Disease
|
NIDA
|
5R01DA010164-12
|
|
The Logics for HIV Risk Among Homeless Heroin Injectors
|
BOURGOIS, PHILIPPE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$360,811
|
|
Liver Disease
|
NIDDK
|
5R01DK067509-03
|
|
AMPK and Mechanisms of Glucose Toxicity
|
RUDERMAN, NEIL
|
BOSTON MEDICAL CENTER
|
MA
|
$255,967
|
|
Liver Disease
|
NIDDK
|
5R01DK057993-07
|
|
Pathophysiology of Biliary Cryptosporidiosis
|
LARUSSO, NICHOLAS
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$306,252
|
|
Liver Disease
|
NIDDK
|
1R01DK078775-01A1
|
|
Inborn Errors of Long Chain Fat Metabolism
|
VOCKLEY, GERARD
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$281,940
|
|
Liver Disease
|
NIGMS
|
4R37GM044100-19
|
|
Nitric Oxide and Hepatic Function in Sepsis and Trauma
|
BILLIAR, TIMOTHY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$303,000
|
|
Liver Disease
|
NIDDK
|
5R01DK054770-08
|
|
T cell modulation of renal ischemia reperfusion injury.
|
RABB, HAMID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$319,921
|
|
Liver Disease
|
NIAAA
|
5R01AA012223-08
|
|
ETHANOL AND OSTEOBLASTOGENESIS: ROLES OF IL-1 AND TNF
|
LUMPKIN, CHARLES
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
AR
|
$261,698
|
|
Liver Disease
|
NIAAA
|
5R01AA011593-09
|
|
Mg2+ homeostasis in liver cells treated with EtOH
|
ROMANI, ANDREA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$244,808
|
|
Liver Disease
|
NIAAA
|
5R01AA013868-06
|
|
Egr1: A candidate molecular target for treating ALD.
|
NAGY, LAURA
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$292,988
|
|
Liver Disease
|
NCI
|
2R01CA086978-06A1
|
|
Molecular mechanism of diet induced carcinogenesis
|
JACOB, SAMSON
|
OHIO STATE UNIVERSITY
|
OH
|
$302,115
|
|
Liver Disease
|
NIDDK
|
5R01DK053933-09
|
|
CTL Effector Mechanisms in Adenoviral Hepatitis
|
THIELE, DWAIN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$267,446
|
|
Liver Disease
|
NIDDK
|
5R01DK068361-03
|
|
Role of immature DC in host defense against HCV
|
ANTHONY, DONALD
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$241,111
|
|
Liver Disease
|
NCI
|
5U01CA120475-02
|
|
The Role of mTOR Signaling in Hepatocellular Carcinogenesis
|
KOZMA, SARA
|
UNIVERSITY OF CINCINNATI
|
OH
|
$296,400
|
|
